HIGHLIGHTS
- who: Gaetana Paolella and colleagues from the European Laboratory for the Investigation of Food-Induced Diseases (ELFID), University of Salerno, Fisciano, SA, Italy have published the article: Type 2 Transglutaminase in Coeliac Disease: A Key Player in Pathogenesis, Diagnosis and Therapy, in the Journal: (JOURNAL)
- what: Regarding CD, TG2 is not only the main autoantigen; it represents one of the most important pathogenetic agents in the disease, and as a consequence, it is one of the possible targets of studies aiming to develop new therapeutical strategies . A revised version of the model proposes that TG2 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.